-
Something wrong with this record ?
Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy
B. Kruspig, K. Valter, B. Skender, B. Zhivotovsky, V. Gogvadze,
Language English Country Netherlands
Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Apoptosis drug effects MeSH
- Drug Resistance, Neoplasm MeSH
- Molecular Targeted Therapy * MeSH
- Cisplatin pharmacology MeSH
- Succinic Acid metabolism MeSH
- Humans MeSH
- Mitochondria drug effects enzymology MeSH
- Cell Line, Tumor MeSH
- Neoplasm Proteins antagonists & inhibitors MeSH
- Neuroblastoma pathology MeSH
- Oxidation-Reduction MeSH
- Antineoplastic Agents pharmacology MeSH
- Reactive Oxygen Species metabolism MeSH
- Electron Transport Complex II antagonists & inhibitors MeSH
- Drug Screening Assays, Antitumor MeSH
- Oxygen Consumption drug effects MeSH
- Superoxides metabolism MeSH
- Drug Synergism MeSH
- Thenoyltrifluoroacetone pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
Mitochondria play a pivotal role in apoptosis: permeabilization of the outer mitochondrial membrane and the release of pro-apoptotic proteins from the intermembrane space of mitochondria are regarded as the key event in apoptosis induction. Here we demonstrate how non-toxic doses of the mitochondrial Complex II inhibitor thenoyltrifluoroacetone (TTFA), which specifically inhibits the ubiquinone-binding site of succinate dehydrogenase (SDH), synergistically stimulated cell death, induced by harmless doses of cisplatin in a panel of chemoresistant neuroblastoma cell lines. Apoptotic cell death was confirmed by cytochrome c release from the mitochondria, cleavage of poly ADP-ribose polymerase, processing of caspase-3, which is an important executive enzyme in apoptosis, and caspase-3-like activity. Methyl malonate, an inhibitor of the SDHA subunit partially reversed apoptosis stimulated by TTFA in SK-N-BE(2) neuroblastoma cells (NB), indicating that sensitization requires oxidation of succinate. In contrast, in IMR-32 NB cells, the same concentrations of TTFA markedly suppressed cisplatin-induced apoptosis. Comparison of oxygen consumption in cisplatin-resistant SK-N-BE(2) and cisplatin-sensitive IMR-32 cells clearly demonstrated impaired Complex II activity in IMR-32 cells. We also found that in SK-N-BE(2) cells co-treatment with cisplatin and TTFA markedly stimulated formation of reactive oxygen species (ROS), whereas in IMR cells, cisplatin-mediated ROS production was attenuated by TTFA, which explains apoptosis suppression in these cells. Thus, functionally active SDH is a prerequisite for the ROS-mediated sensitization to treatment by TTFA.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017276
- 003
- CZ-PrNML
- 005
- 20180515103128.0
- 007
- ta
- 008
- 180515s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbamcr.2016.04.026 $2 doi
- 035 __
- $a (PubMed)27140478
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kruspig, Björn $u Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, Stockholm, SE-171 77, Sweden.
- 245 10
- $a Targeting succinate:ubiquinone reductase potentiates the efficacy of anticancer therapy / $c B. Kruspig, K. Valter, B. Skender, B. Zhivotovsky, V. Gogvadze,
- 520 9_
- $a Mitochondria play a pivotal role in apoptosis: permeabilization of the outer mitochondrial membrane and the release of pro-apoptotic proteins from the intermembrane space of mitochondria are regarded as the key event in apoptosis induction. Here we demonstrate how non-toxic doses of the mitochondrial Complex II inhibitor thenoyltrifluoroacetone (TTFA), which specifically inhibits the ubiquinone-binding site of succinate dehydrogenase (SDH), synergistically stimulated cell death, induced by harmless doses of cisplatin in a panel of chemoresistant neuroblastoma cell lines. Apoptotic cell death was confirmed by cytochrome c release from the mitochondria, cleavage of poly ADP-ribose polymerase, processing of caspase-3, which is an important executive enzyme in apoptosis, and caspase-3-like activity. Methyl malonate, an inhibitor of the SDHA subunit partially reversed apoptosis stimulated by TTFA in SK-N-BE(2) neuroblastoma cells (NB), indicating that sensitization requires oxidation of succinate. In contrast, in IMR-32 NB cells, the same concentrations of TTFA markedly suppressed cisplatin-induced apoptosis. Comparison of oxygen consumption in cisplatin-resistant SK-N-BE(2) and cisplatin-sensitive IMR-32 cells clearly demonstrated impaired Complex II activity in IMR-32 cells. We also found that in SK-N-BE(2) cells co-treatment with cisplatin and TTFA markedly stimulated formation of reactive oxygen species (ROS), whereas in IMR cells, cisplatin-mediated ROS production was attenuated by TTFA, which explains apoptosis suppression in these cells. Thus, functionally active SDH is a prerequisite for the ROS-mediated sensitization to treatment by TTFA.
- 650 _2
- $a protinádorové látky $x farmakologie $7 D000970
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a cisplatina $x farmakologie $7 D002945
- 650 _2
- $a chemorezistence $7 D019008
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a synergismus léků $7 D004357
- 650 _2
- $a respirační komplex II $x antagonisté a inhibitory $7 D042963
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x účinky léků $x enzymologie $7 D008928
- 650 12
- $a cílená molekulární terapie $7 D058990
- 650 _2
- $a nádorové proteiny $x antagonisté a inhibitory $7 D009363
- 650 _2
- $a neuroblastom $x patologie $7 D009447
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a spotřeba kyslíku $x účinky léků $7 D010101
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a kyselina jantarová $x metabolismus $7 D019802
- 650 _2
- $a superoxidy $x metabolismus $7 D013481
- 650 _2
- $a thenoyltrifluoraceton $x farmakologie $7 D013804
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Valter, Kadri $u Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, Stockholm, SE-171 77, Sweden.
- 700 1_
- $a Skender, Belma $u Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, Stockholm, SE-171 77, Sweden; Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Královopolská 135, 612 65 Brno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Faculty of Science, Masaryk University, Terezy Novákové 64, 621 00 Brno, Czech Republic.
- 700 1_
- $a Zhivotovsky, Boris $u Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, Stockholm, SE-171 77, Sweden; MV Lomonosov Moscow State University, 119991 Moscow, Russia.
- 700 1_
- $a Gogvadze, Vladimir $u Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Box 210, Stockholm, SE-171 77, Sweden; MV Lomonosov Moscow State University, 119991 Moscow, Russia. Electronic address: Vladimir.Gogvadze@ki.se.
- 773 0_
- $w MED00009314 $t Biochimica et biophysica acta $x 0006-3002 $g Roč. 1863, č. 8 (2016), s. 2065-71
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27140478 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180515103302 $b ABA008
- 999 __
- $a ok $b bmc $g 1300900 $s 1014116
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 1863 $c 8 $d 2065-71 $e 20160429 $i 0006-3002 $m Biochimica et biophysica acta $n Biochim Biophys Acta $x MED00009314
- LZP __
- $a Pubmed-20180515
